Gabapentin Withdrawal Syndrome : Clinical Neuropharmacology

Journal Logo

Brief Reports

Gabapentin Withdrawal Syndrome

Norton, John W.

Author Information
Clinical Neuropharmacology 24(4):p 245-246, July 2001.


Gabapentin (GBP) has gained wide acceptance in the treatment of pain, migraine, bipolar illness, and epilepsy. It has a relatively benign side effect profile, lacks significant drug interactions, is not liver metabolized, and is renally excreted. Herein three cases are presented that demonstrate withdrawal symptoms after abrupt discontinuation of GBP. Clinicians are encouraged to taper GBP dosage, especially when patients have taken high doses, and to warn patients of possible adverse effects of abruptly discontinuing GBP themselves.

© 2001 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid